Babak Alipanahi

Babak Alipanahi

babaka.bsky.social

computational biology, artificial intelligence and large-scale datasets to improve human health

👤 Joined on 09 October 2023

1138

Followers

323

Following

87

Total Posts

📜 Kullanıcı Geçmişi

  • 09 Eki 2023, 23:00
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @babak-a.bsky.social
  • 12 Eki 2023, 06:18
    ✏️ Kullanıcı adı değişti: @babak-a.bsky.social → @babaka7i.bsky.social
  • 28 Eki 2023, 06:30
    ✏️ Kullanıcı adı değişti: @babaka7i.bsky.social → @babak-alipanahi.bsky.social
  • 28 Eki 2023, 06:36
    ✏️ Kullanıcı adı değişti: @babak-alipanahi.bsky.social → @babak-a.bsky.social
  • 09 Kas 2023, 18:30
    🔄 Profil bilgileri güncellendi
  • 04 Şub 2026, 19:13
    ✏️ Kullanıcı adı değişti: @babak-a.bsky.social → @babaka.bsky.social

❤️ Beğendiği Gönderiler

A new feature @science.org on the clusters of cells that enhance the spread of cancer, and what can be done to break them up www.science.org/content/arti...

Show Post

Were you inspired by our paper on the genetics of GLP-1 drug response? www.nature.com/articles/s41... Want to make impactful discoveries with the world's best genetic dataset? We're hiring! StatGen: tinyurl.com/ys4mvhej Risk Prediction: tinyurl.com/psamt294 Data Products: tinyurl.com/2ff7eavb

Show Post

GLP-1 weight loss drugs come with a major caveat: They don’t work for everyone. A new study finds that part of the reason people’s responses to the drugs vary so widely may be in their DNA.

Show Post
STAT
08 April 2026 18:07

Specific changes in two genes appear to help predict whether patients will lose substantial weight on GLP-1 drugs used to treat obesity — and whether the drugs will cause nausea or vomiting. www.statnews.com/2026/04/08/2...

Show Post
Nature
08 April 2026 17:48

Scientists have identified a set of genetic variants that could help to explain why responses to obesity drugs vary markedly from person to person go.nature.com/4ccK07M

Show Post

Select language

Install App

Install App